Essential Tremor

1. Disease Information

Overview

Essential tremor (ET) is the most common neurological movement disorder worldwide, characterized by bilateral, rhythmic, involuntary action tremor primarily affecting the upper limbs at frequencies of 4–12 Hz (ortegarobles2025tremorclinicalframeworks pages 13-15, ortegarobles2025tremorclinicalframeworks pages 2-4). It manifests predominantly as postural and kinetic tremor, impairing activities of daily living including writing, drinking, and eating (buyukserbetci2025clinicalandgenetic pages 1-2). Unlike resting tremor seen in Parkinson's disease (PD), ET is not typically observed at rest. The 2018 consensus criteria of the International Parkinson and Movement Disorder Society (IPMDS) redefined ET as a heterogeneous syndrome with variable clinical features and diverse underlying mechanisms, moving beyond the previous classification of it as purely idiopathic or familial (ortegarobles2025tremorclinicalframeworks pages 2-4).

Key Identifiers

• MONDO: MONDO:0003233 (OpenTargets Search: Essential Tremor)
• OMIM: ETM1 (OMIM 190300) mapped to 3q13; ETM2 mapped to 2p22-24 (buyukserbetci2025clinicalandgenetic pages 1-2)
• ICD-10: G25.0 (Essential tremor)
• MeSH: D020329 (Essential Tremor)
• Orphanet: ORPHA:228
• Common Synonyms: Benign essential tremor, familial tremor, hereditary essential tremor, idiopathic tremor, senile tremor

Disease Category

ET is classified as a complex, multifactorial neurological disorder with both genetic and environmental contributions (buyukserbetci2025clinicalandgenetic pages 1-2, kuhlenbaumer2014geneticsofessential pages 1-3).

2. Etiology

Causal Factors

ET develops through multifactorial genetic and environmental interactions rather than simple Mendelian inheritance (buyukserbetci2025clinicalandgenetic pages 1-2). Twin study concordance rates of 69–93% in monozygotic twins and 27–29% in dizygotic twins confirm the strong genetic component alongside environmental contributions (buyukserbetci2025clinicalandgenetic pages 1-2).

Genetic Risk Factors

Family history is present in 30–70% of ET patients, with first-degree relatives showing a 4.7-fold increased risk (ortegarobles2025tremorclinicalframeworks pages 13-15, kuhlenbaumer2014geneticsofessential pages 1-3). GWAS studies have identified numerous susceptibility loci:

• Skuladottir et al. (2024): A landmark GWAS meta-analysis comprising 16,480 ET cases and 1,936,173 controls identified 12 sequence variants at 11 loci, with 8 being novel, explaining ~4.4% of genetic variance. Seven putative causal genes were highlighted, including CA3 (Carbonic Anhydrase III) and CPLX1 (Complexin-1). Gene-set enrichment identified associations with dopaminergic and GABAergic neurons, and genetic correlation with PD (rg = 0.28) and depression (rg = 0.15) (skuladottir2024gwasmetaanalysisreveals pages 1-2, skuladottir2024gwasmetaanalysisreveals pages 2-4).

• Ogonowski et al. (2025): A genome-wide meta-analysis of 20,268 ET cases and 723,761 controls identified 50 independent loci (47 novel). SNP-based heritability was estimated at 24% (18.5% on the liability scale). Key implicated genes include BACE2, CACNA1A, PPARGC1A, and PPM1J. Spatial transcriptomics highlighted enrichment in hippocampal and cortical excitatory neurons, astrocytes, and microglia (ogonowski2025genomewidemetaanalysisidentifies pages 3-5, ogonowski2025genomewidemetaanalysisidentifies pages 7-9, ogonowski2025genomewidemetaanalysisidentifies pages 1-3).

Previously established candidate genes include LINGO1 (first ET GWAS signal, rs9652490; p = 1.2 × 10⁻²⁹), FUS (stop-gain variant in a Franco-Canadian family), TENM4 (missense mutations affecting axon guidance and myelination), and STK32B (rs10937625; OR = 1.50 in Chinese populations) (kuhlenbaumer2014geneticsofessential pages 1-3, kuhlenbaumer2014geneticsofessential pages 4-6, cao2023associationanalysisof pages 7-8).

Environmental Risk Factors

Harmane (a β-carboline) exposure has been identified as a potential environmental trigger, and the harmaline model demonstrates the tremorigenic properties of this compound class (kosmowska2023gabaaalpha23 pages 2-3). Age is the strongest non-genetic risk factor, with prevalence increasing dramatically after 65 years (ortegarobles2025tremorclinicalframeworks pages 13-15). Potential roles for Toxoplasma gondii and Toxocara spp. infections as etiologic factors have been explored in preliminary studies.

Protective Factors

Approximately 50–75% of ET patients report temporary tremor suppression from alcohol consumption (kuhlenbaumer2014geneticsofessential pages 1-3). This response has been mechanistically linked to modulation of extra-synaptic α6β3δ GABAA receptors on cerebellar granule cells (handforth2023searchfornovel pages 1-2, kuo2023gabaareceptorsubtype pages 1-2).

Gene-Environment Interactions

Recent gut microbiome research demonstrates a novel gene-environment interaction axis: ET patients show reduced GABA-producing gut bacteria and lower fecal GABA concentrations, and fecal microbiota transplantation from ET patients into mice extends tremor duration (zhong2023supplementationwithhighgabaproducing pages 7-14, zhong2023supplementationwithhighgabaproducing pages 1-2). This suggests that gut microbial GABA production, transmitted via the enteric nervous system–vagus nerve–brain axis, interacts with genetic predisposition to influence disease expression (zhong2023supplementationwithhighgabaproducing pages 14-17).

The following table summarizes the key genetic loci and candidate genes associated with ET:

Table: This table summarizes major ET-associated genes across GWAS, familial/exome, and repeat-expansion studies, with emphasis on the 2024 and 2025 large-scale genetic analyses. It is useful for linking named candidate genes to their study context, evidence type, and current level of support.

3. Phenotypes

Motor Phenotypes

• Postural tremor (HP:0002174): Bilateral upper limb tremor while maintaining posture against gravity; present in virtually all ET patients (ortegarobles2025tremorclinicalframeworks pages 15-16, ortegarobles2025tremorclinicalframeworks pages 13-15).
• Kinetic tremor (HP:0030186): Tremor during voluntary movement, often of greater amplitude than postural tremor; the hallmark feature of ET (ortegarobles2025tremorclinicalframeworks pages 15-16, ortegarobles2025tremorclinicalframeworks pages 13-15).
• Intention tremor (HP:0002080): Present in many patients; worsens during goal-directed movement toward a target (ortegarobles2025tremorclinicalframeworks pages 15-16).
• Head tremor (HP:0002346): Develops after years of upper limb involvement; more common in women (ortegarobles2025tremorclinicalframeworks pages 15-16).
• Voice tremor (HP:0001618): Laryngeal tremor causing vocal quavering; develops with disease progression (ortegarobles2025tremorclinicalframeworks pages 15-16).

Non-Motor Phenotypes

• Cognitive deficits, including mild cognitive impairment progressing in some cases
• Depression and anxiety (genetically correlated with ET; rg = 0.15 for depression) (skuladottir2024gwasmetaanalysisreveals pages 2-4)
• Sensory abnormalities (ortegarobles2025tremorclinicalframeworks pages 15-16)

Phenotype Characteristics

• Age of onset: Bimodal distribution with peaks in early adulthood (~20 years) and late life (~60 years) (kuhlenbaumer2014geneticsofessential pages 1-3)
• Severity: Variable, from mild to severely disabling; progressive over decades
• Progression: Tremor amplitude increases over time; initially limited to arms, may extend to head, voice, jaw, and legs (ortegarobles2025tremorclinicalframeworks pages 15-16, ortegarobles2025tremorclinicalframeworks pages 13-15)
• Frequency: Affects approximately 1–5% of the population aged >65 years (ortegarobles2025tremorclinicalframeworks pages 13-15)

ET-Plus Classification

ET-plus represents patients exhibiting the core ET phenotype plus additional soft neurological signs including impaired tandem gait, questionable dystonic posturing, mild cognitive complaints, or rest tremor not meeting criteria for PD (ortegarobles2025tremorclinicalframeworks pages 15-16, erro2023diagnosisversusclassification pages 2-3, ortegarobles2025tremorclinicalframeworks pages 10-12). ET-plus patients tend to be older at onset, have more severe tremor, and show greater head/voice involvement (ortegarobles2025tremorclinicalframeworks pages 15-16).

Quality of Life Impact

Greater tremor severity (measured by TETRAS Performance Item 4) is positively correlated with activities of daily living impairment (Pearson r = 0.761) and negatively associated with quality of life (EQ-5D-5L: r = −0.410; QUEST: r = 0.457) (ortegarobles2025tremorclinicalframeworks pages 12-13). Up to 92.8% of affected individuals in population-based studies are unaware of their diagnosis, indicating substantial under-recognition (ortegarobles2025tremorclinicalframeworks pages 13-15).

4. Genetic/Molecular Information

Causal Genes and Pathogenic Variants

ET is genetically complex, with most cases arising from polygenic risk rather than monogenic mutations (kuhlenbaumer2014geneticsofessential pages 1-3). Key genetic findings include:

• TENM4 (ENSG00000149256): Missense mutations affecting axon guidance and central myelination; strongest OpenTargets association score (0.685) (OpenTargets Search: Essential Tremor, cao2023associationanalysisof pages 7-8)
• FUS (ENSG00000089280): Stop mutation c.868C>T (p.Gln290*) identified in familial ET; limited replication in other families (kuhlenbaumer2014geneticsofessential pages 4-6, OpenTargets Search: Essential Tremor)
• BACE2 (ENSG00000182240): ET-associated variants causally linked to BACE2 downregulation in cerebellar immature oligodendrocytes via single-cell eQTL analysis; suggestive of demyelination (castonguay2024asinglecelleqtl pages 1-5, ogonowski2025genomewidemetaanalysisidentifies pages 9-11)
• NOTCH2NLC (ENSG00000286219): GGC repeat expansions associated with hereditary essential tremor type 6 and NIID-spectrum overlap (OpenTargets Search: Essential Tremor)
• DRD3 (ENSG00000151577): Dopamine receptor D3; Phase 3 clinical trial evidence exists (OpenTargets Search: Essential Tremor)

SNP-Based Heritability

Common variants explain approximately 24% of phenotypic variance in ET (h² = 0.24, SE = 0.02), corresponding to 18.5% on the liability scale at 5% population prevalence (ogonowski2025genomewidemetaanalysisidentifies pages 3-5, ogonowski2025genomewidemetaanalysisidentifies pages 1-3).

Epigenetic Information

No well-established epigenetic biomarkers are currently validated for ET. However, transcriptomic studies suggest RNA splicing dysregulation in Purkinje cells, with differentially expressed spliceosome complex components (RBM25, PRPF38B, PNN, SREK1) identified in laser-captured ET Purkinje cells (martuscello2023geneexpressionanalysis pages 9-11).

5. Environmental Information

Environmental Factors

Harmane (1-methyl-9H-pyrido[3,4-b]indole), a β-carboline found in cooked meats and cigarette smoke, has been epidemiologically associated with ET (kosmowska2023gabaaalpha23 pages 2-3). The harmaline model directly demonstrates the tremorigenic potential of β-carboline compounds.

Lifestyle Factors

Alcohol consumption (ethanol at non-intoxicating doses) temporarily suppresses tremor in 50–75% of patients, acting via cerebellar α6β3δ extra-synaptic GABAA receptors (kuhlenbaumer2014geneticsofessential pages 1-3, handforth2023searchfornovel pages 1-2). Dietary GABA intake and gut microbiome composition may modulate disease through the gut-brain axis (zhong2023supplementationwithhighgabaproducing pages 7-14, zhong2023supplementationwithhighgabaproducing pages 14-17).

Gut Microbiome

ET patients demonstrate reduced gut microbial GABA-producing capacity and lower fecal GABA concentration compared to healthy controls (zhong2023supplementationwithhighgabaproducing pages 7-14, zhong2023supplementationwithhighgabaproducing pages 1-2). Supplementation with high-GABA-producing Lactobacillus plantarum L5 (producing 262 mg/L GABA) ameliorated tremor in mouse models by reshaping gut microbial composition, increasing cerebellar GABA concentrations, and diminishing CNS inflammation (zhong2023supplementationwithhighgabaproducing pages 5-7, zhong2023supplementationwithhighgabaproducing pages 1-2).

6. Mechanism / Pathophysiology

Cerebello-Thalamo-Cortical Circuit Dysfunction

ET pathophysiology centers on dysfunction within the cerebello-thalamo-cortical circuit, with multiple complementary mechanisms proposed (ortegarobles2025tremorclinicalframeworks pages 13-15, ortegarobles2025tremorclinicalframeworks pages 6-8):

1. Cerebellar oscillator hypothesis: Excessive cerebellar activity in sensorimotor lobes generates tremor-related rhythmic discharges (ortegarobles2025tremorclinicalframeworks pages 6-8)
2. Cerebellar decoupling hypothesis: Structural and functional disconnection between the cerebellum and its targets (dentate nucleus, thalamus) causes aberrant output (ortegarobles2025tremorclinicalframeworks pages 6-8)
3. Central oscillatory network hypothesis: Synchronized oscillatory activity across the cerebellum, inferior olive, thalamus, and motor cortex collectively generates tremor (ortegarobles2025tremorclinicalframeworks pages 13-15)

Purkinje Cell Pathology

Purkinje cells (CL:0000121), the sole output neurons of the cerebellar cortex, exhibit multiple structural and functional abnormalities in ET (camargo2025thecerebellarinvolvement pages 2-4, camargo2025thecerebellarinvolvement pages 1-2, martuscello2023geneexpressionanalysis pages 12-14): - Expansion of climbing fiber synaptic territory into parallel fiber zones, correlating with tremor severity - Purkinje cell loss and axonal torpedo formation - Dendritic spine loss and morphological changes - Reduced GluRδ2 protein expression leading to deficient synaptic pruning of climbing fibers - Gene expression dysregulation including RNA splicing components, calcium signaling genes (CACNA1G, ITPR1), and inflammatory markers (IL-2, IL-6) (martuscello2023geneexpressionanalysis pages 9-11, martuscello2023geneexpressionanalysis pages 6-7)

GABAergic Dysfunction

Postmortem analysis reveals reduced GABA-A and GABA-B receptor binding in the dentate nucleus of ET patients (camargo2025thecerebellarinvolvement pages 2-4). GABA-A receptor α1 subunit loss from Purkinje cells is sufficient to induce tremor in mouse models (kosmowska2023gabaaalpha23 pages 16-17, pan2026circuitrydynamicsof pages 32-34). However, the primary source of GABAergic dysfunction is debated—it may be a consequence rather than a cause of Purkinje cell pathology (gironell2022isessentialtremor pages 1-2).

Olivocerebellar Circuit

The inferior olive's intrinsic oscillatory properties influence Purkinje cell pacemaking through climbing fiber connections (camargo2025thecerebellarinvolvement pages 2-4, camargo2025thecerebellarinvolvement pages 1-2). Harmaline directly enhances coupling of inferior olivary neurons, which then entrain Purkinje cells to fire synchronously (kuo2023gabaareceptorsubtype pages 1-2, woodward2022cerebellothalamocorticalnetworkdynamics pages 1-2).

Oligodendrocyte Vulnerability

A groundbreaking single-cell eQTL atlas of the human cerebellum (>1 million cells from 109 individuals) revealed that ET-associated genetic variants at the BACE2 locus are causally linked to BACE2 downregulation specifically in cerebellar oligodendrocytes (castonguay2024asinglecelleqtl pages 1-5). A genetically vulnerable subpopulation of BACE2-expressing immature oligodendrocytes was identified, displaying altered mRNA related to axonal and synaptic homeostasis suggestive of demyelination (castonguay2024asinglecelleqtl pages 1-5, castonguay2024asinglecelleqtl pages 45-47). Dysfunctional interactions between Golgi cells, Purkinje layer interneurons, and oligodendrocytes were also observed in ET tissue (castonguay2024asinglecelleqtl pages 1-5).

Molecular Pathways

Key pathways implicated include: - Calcium signaling (GO:0005509, GO:0019722) — including CACNA1G, CACNA1A, CaMKK2 (martuscello2023geneexpressionanalysis pages 9-11, castonguay2022transcriptomiceffectsof pages 3-4) - Rho GTPase signaling (GO:0007264) (skuladottir2024gwasmetaanalysisreveals pages 1-2) - Axon guidance (GO:0007411) — Semaphorin interactions, RUNX1-mediated growth cone guidance (castonguay2022transcriptomiceffectsof pages 3-4) - Endosomal sorting (castonguay2022transcriptomiceffectsof pages 1-2) - GABAergic neurotransmission (GO:0007214) (ortegarobles2025tremorclinicalframeworks pages 13-15, camargo2025thecerebellarinvolvement pages 2-4) - Glutamatergic signaling via GluRδ2 (ortegarobles2025tremorclinicalframeworks pages 13-15)

Molecular Profiling

• Transcriptomics: Purkinje cell gene expression analysis identified 36 differentially expressed genes including spliceosome components (RBM25, PRPF38B, PNN, SREK1) and dysregulated calcium signaling (martuscello2023geneexpressionanalysis pages 9-11, martuscello2023geneexpressionanalysis pages 6-7). Pathway enrichment revealed 98 significantly altered pathways including autophagy, stress/inflammation, and DNA damage pathways (martuscello2023geneexpressionanalysis pages 6-7).
• Pharmacogenomics: Transcriptomic effects of propranolol and primidone converge on calcium signaling (q = 4.67×10⁻⁷), axon guidance (q = 1.68×10⁻⁸), GPCR signaling (q = 1.12×10⁻¹⁹), and neuronal morphology pathways (castonguay2022transcriptomiceffectsof pages 1-2, castonguay2022transcriptomiceffectsof pages 3-4). Propranolol affected expression of TRAPPC11, previously associated with ET and movement disorders (castonguay2022transcriptomiceffectsof pages 1-2).

7. Anatomical Structures Affected

Organ Level

• Primary: Cerebellum (UBERON:0002037) — central to pathophysiology (camargo2025thecerebellarinvolvement pages 2-4, camargo2025thecerebellarinvolvement pages 1-2)
• Thalamus (UBERON:0001897): Ventral intermediate nucleus (VIM) — key relay in tremor circuit (ortegarobles2025tremorclinicalframeworks pages 13-15, camargo2025thecerebellarinvolvement pages 7-8)
• Inferior olive (UBERON:0002153): Intrinsic oscillatory nucleus driving Purkinje cell synchrony (camargo2025thecerebellarinvolvement pages 2-4)
• Motor cortex (UBERON:0001384): Receives aberrant thalamic output (ortegarobles2025tremorclinicalframeworks pages 13-15)
• Ventral diencephalon: Inverse genetic correlations with ET identified via neuroimaging genomics (ogonowski2025genomewidemetaanalysisidentifies pages 3-5)

Tissue and Cell Level

• Purkinje cells (CL:0000121): Primary cellular site of pathology (camargo2025thecerebellarinvolvement pages 2-4, gironell2022isessentialtremor pages 1-2)
• Cerebellar granule cells (CL:0001031): Express α6β3δ GABAA receptors mediating alcohol response (handforth2023searchfornovel pages 1-2)
• Oligodendrocytes (CL:0000128): BACE2-expressing immature oligodendrocytes vulnerable in ET (castonguay2024asinglecelleqtl pages 1-5, castonguay2024asinglecelleqtl pages 45-47)
• Basket cells and Golgi cells: Altered inhibitory connections around Purkinje cells (camargo2025thecerebellarinvolvement pages 2-4, castonguay2024asinglecelleqtl pages 1-5)
• Bergmann glia (CL:0000644): Reduced process terminations reported in ET cerebellum (castonguay2024asinglecelleqtl pages 31-33)
• Dopaminergic neurons and GABAergic neurons: Enriched in gene-set analyses of ET GWAS data (skuladottir2024gwasmetaanalysisreveals pages 1-2)

Lateralization

ET typically presents bilaterally but may be asymmetric; kinetic tremor is often more prominent on the dominant hand side (ortegarobles2025tremorclinicalframeworks pages 15-16, ortegarobles2025tremorclinicalframeworks pages 10-12).

8. Temporal Development

Onset

Age of onset follows a bimodal distribution with peaks in early adulthood (~20 years) and late life (~60 years), with an additional smaller peak near childhood (kuhlenbaumer2014geneticsofessential pages 1-3). Onset is insidious and chronic, with gradual worsening over decades (ortegarobles2025tremorclinicalframeworks pages 15-16, ortegarobles2025tremorclinicalframeworks pages 13-15).

Progression

Tremor amplitude progressively increases over time, and anatomical spread extends from upper limbs to head, voice, jaw, and legs after years of disease progression (ortegarobles2025tremorclinicalframeworks pages 15-16, ortegarobles2025tremorclinicalframeworks pages 13-15). The condition is chronic and lifelong with no spontaneous remission. Disease duration correlates with greater functional impairment and broader body region involvement.

ET-to-PD Conversion

A prospective longitudinal study of 193 ET patients (mean age 78.1 years, mean follow-up 4.1 years) found that 3.6% converted from ET to ETPD, with incidence of 882.8 per 100,000 person-years — 2 to 6.5 times higher than the general population rate (louis2023conversionrateof pages 4-5, louis2023conversionrateof pages 1-2). A Spanish population-based cohort reported 3.0% ET-to-PD conversion over median 3.3-year follow-up, with adjusted relative risk of 4.27 (louis2025theassociationbetween pages 4-5). Lifetime risk estimates suggest 8.5% of men and 5.6% of women with ET will develop PD, compared to 2.0% and 1.3% respectively in those without ET (louis2025theassociationbetween pages 4-5).

9. Inheritance and Population

Epidemiology

• Global prevalence: Meta-analyses report 0.32–1.33% across all ages, increasing to 2.87–5.79% in those over 65 years (ortegarobles2025tremorclinicalframeworks pages 13-15)
• US prevalence: Age-standardized diagnosed prevalence of 0.42%, corresponding to approximately 1.1 million US adults in 2024; age-stratified rates range from 0.06% (18–40 years) to 1.61% (≥75 years) (lin2025prevalenceofdiagnosed pages 1-2, lin2025prevalenceofdiagnosed pages 8-10)
• German prevalence: 196–250 per 100,000 persons in 2021 (becktepe2025epidemiologyandtreatment pages 1-2)
• Under-recognition: Up to 92.8% of individuals with ET in population-based studies are unaware of their diagnosis (ortegarobles2025tremorclinicalframeworks pages 13-15)

Inheritance Pattern

ET is genetically complex (multifactorial/polygenic) with occasional families showing autosomal dominant-like segregation patterns (kuhlenbaumer2014geneticsofessential pages 1-3, buyukserbetci2025clinicalandgenetic pages 1-2). Penetrance is incomplete and variable; expressivity is highly variable across individuals and families.

Sex Distribution

ET affects men and women approximately equally, though some data suggest slightly higher prevalence in men, and ET-to-PD conversion rates are higher in men (6.9%) than women (1.65%) (ortegarobles2025tremorclinicalframeworks pages 13-15, louis2023conversionrateof pages 4-5).

Population Demographics

ET is found in all ethnic and geographic populations studied. Genetic risk factors may differ across populations — for example, rs10937625 in STK32B is associated with ET risk specifically in eastern Chinese populations (cao2023associationanalysisof pages 7-8).

10. Diagnostics

Clinical Criteria

The 2018 IPMDS consensus criteria define ET as isolated bilateral upper limb action tremor of at least 3 years' duration without additional neurological signs (dystonia, ataxia, parkinsonism) (ortegarobles2025tremorclinicalframeworks pages 15-16, ortegarobles2025tremorclinicalframeworks pages 2-4). Diagnosis is primarily clinical, employing a two-axis system: Axis 1 (syndromic diagnosis) and Axis 2 (etiology) (ortegarobles2025tremorclinicalframeworks pages 2-4).

Clinical Assessment Tools

• TETRAS (Essential Tremor Rating Assessment Scale): Performance subscale and ADL subscale; validated for clinical trials (ortegarobles2025tremorclinicalframeworks pages 12-13)
• Clinical Rating Scale for Tremor (CRST/Fahn-Tolosa-Marín): Evaluates tremor severity across body parts (ortegarobles2025tremorclinicalframeworks pages 12-13)
• QUEST (Quality of Life in Essential Tremor Questionnaire): Disease-specific QoL tool (ortegarobles2025tremorclinicalframeworks pages 12-13, NCT04748640 chunk 1)
• Accelerometry and EMG: Supportive diagnostic tools for quantifying tremor frequency and amplitude in complex cases (ortegarobles2025tremorclinicalframeworks pages 15-16)

Differential Diagnosis

Key conditions to differentiate from ET include enhanced physiological tremor, parkinsonian tremor (rest > action), dystonic tremor, cerebellar tremor, orthostatic tremor, and functional tremor (ortegarobles2025tremorclinicalframeworks pages 10-12). Distinction from PD relies on differentiating postural vs. re-emergent tremor patterns, finger pronation-supination movements, and associated neurological signs (ortegarobles2025tremorclinicalframeworks pages 15-16). DAT-SPECT imaging can help distinguish ET from PD, and neuromelanin-sensitive MRI has shown promise (ortegarobles2025tremorclinicalframeworks pages 10-12).

Genetic Testing

Genetic testing for ET is not routinely recommended as no single causal gene accounts for a substantial proportion of cases (kuhlenbaumer2014geneticsofessential pages 1-3). Short tandem repeat (STR) expansion testing may be considered to rule out spinocerebellar ataxias and NIID in cases with overlapping phenotypes; among 515 familial ET probands, 3.7% carried intermediate or pathogenic STR expansions in ataxia-associated genes (cao2023associationanalysisof pages 7-8).

11. Outcome/Prognosis

Survival and Mortality

ET is not directly life-threatening, and most patients have near-normal life expectancy. However, ET serves as a significant risk factor for PD (4–5-fold increased risk) (louis2025theassociationbetween pages 4-5, louis2023conversionrateof pages 1-2), and mild cognitive impairment and dementia risks are elevated in ET populations.

Morbidity and Function

ET causes progressive functional disability affecting manual dexterity, social activities, and occupational performance. Greater tremor amplitude strongly predicts ADL impairment (r = 0.761) and reduced QoL (ortegarobles2025tremorclinicalframeworks pages 12-13). Common comorbidities include pain disorders (65–70%), hypertension (44–65%), and hyperlipidemia (30–35%) (becktepe2025epidemiologyandtreatment pages 1-2).

12. Treatment

The following table summarizes established and experimental treatments for essential tremor:

Table: This table summarizes established, surgical, and investigational therapies for essential tremor, including mechanisms, approximate efficacy where reported, adverse effects, and current evidence level. It is useful for comparing standard-of-care options with newer agents and device-based interventions in development.

Pharmacotherapy

First-line: Propranolol (the only FDA-approved medication for ET) and primidone are the standard treatments, each reducing tremor amplitude by approximately 50–70% in responders (ortegarobles2025tremorclinicalframeworks pages 16-18, lin2025prevalenceofdiagnosed pages 1-2). However, long-term adherence is limited by side effects and declining efficacy. In Germany, approximately 60% of diagnosed patients receive pharmacotherapy, with propranolol prescribed in 44–50% of treated patients (becktepe2025epidemiologyandtreatment pages 1-2). Medication discontinuation rates range from 10–70%, with 72–75% discontinuing first therapy within 12 months (becktepe2025epidemiologyandtreatment pages 1-2).

Second-line: Topiramate, gabapentin, alprazolam, and botulinum toxin injections for refractory head or voice tremor (ortegarobles2025tremorclinicalframeworks pages 16-18, zhang2024treatmentforessential pages 13-13).

Surgical Interventions

Deep brain stimulation (DBS) of the VIM thalamic nucleus achieves tremor reduction of 53.4–62.8% after 12 months unilaterally, and 66–78% bilaterally with better axial and voice tremor control (camargo2025thecerebellarinvolvement pages 7-8). MRI-guided focused ultrasound (MRgFUS) thalamotomy offers a non-invasive alternative; bilateral staged procedures achieved ~60% reduction in CRST A+B score with marked QoL improvement (camargo2025thecerebellarinvolvement pages 7-8). Peripheral nerve stimulation via transcutaneous afferent patterned stimulation (TAPS) has received regulatory approval (ortegarobles2025tremorclinicalframeworks pages 16-18).

Experimental Therapies

• BP1.4979: A selective dopamine D3 partial agonist currently in Phase 2 trial (NCT07074002) evaluating efficacy via TETRAS-P change over 4 weeks in 50 patients (NCT07074002 chunk 1)
• AGN-151607-DP (gemibotulinumtoxinA): AbbVie Phase 2b trial (NCT07673107) assessing intramuscular injection for upper limb ET in 94 patients over 72 weeks (NCT07673107 chunk 1)
• SAGE-324/BIIB124: Neuroactive steroid GABA-A receptor modulator that demonstrated significant tremor reduction in a Phase 2 study of 67 patients, though dose reductions were required in 62% due to adverse effects (camargo2025thecerebellarinvolvement pages 7-8)
• α6-GABAA receptor modulators: Preclinical evidence shows that targeting cerebellar α6β3δ and α6βγ2 GABAA receptors can suppress tremor with improved tolerability profiles. Flumazenil at low doses suppressed harmaline tremor in wild-type but not α6-knockout mice, providing proof of principle (handforth2023searchfornovel pages 1-2, kuo2023gabaareceptorsubtype pages 1-2)
• Gamma Knife bilateral thalamotomy: Phase II/III trial (NCT04748640) evaluating bilateral treatment in 50 patients (NCT04748640 chunk 1)
• Probiotics: Lactobacillus plantarum L5 supplementation ameliorated ET in mouse models by increasing cerebellar GABA and reducing neuroinflammation (zhong2023supplementationwithhighgabaproducing pages 7-14, zhong2023supplementationwithhighgabaproducing pages 5-7)

MAXO Terms

• MAXO:0000016 (pharmacological treatment)
• MAXO:0000943 (deep brain stimulation)
• MAXO:0001175 (focused ultrasound therapy)
• MAXO:0001001 (botulinum toxin injection)

13. Prevention

Primary Prevention

No established primary prevention strategies exist for ET. Avoiding known environmental triggers such as β-carboline exposure (harmane) may theoretically reduce risk.

Secondary Prevention

The 2018 consensus criteria provide a framework for early clinical identification. However, up to 92.8% of affected individuals remain undiagnosed, indicating a critical need for improved screening (ortegarobles2025tremorclinicalframeworks pages 13-15).

Tertiary Prevention

Management focuses on preventing functional decline through early pharmacotherapy, occupational therapy, and adaptive devices. Monitoring for ET-to-PD conversion is recommended given the 4–5-fold increased risk (louis2025theassociationbetween pages 4-5).

Genetic Counseling

Genetic counseling may be appropriate for families with strong ET history, although the polygenic nature limits predictive testing utility. The SNP-based heritability of ~24% and presence of identified risk loci could eventually support polygenic risk score applications (ogonowski2025genomewidemetaanalysisidentifies pages 1-3).

14. Other Species / Natural Disease

ET is uniquely human in its full clinical presentation, though natural tremor phenotypes occur in other species. The gene TENM4, strongly associated with ET, has orthologs across vertebrates, suggesting conserved axon guidance and myelination functions relevant to tremor mechanisms (cao2023associationanalysisof pages 7-8). The Grid2 gene involved in the murine ET model (Grid2dupE3 mice) shows evolutionary conservation of climbing fiber-Purkinje cell synaptic biology (pan2025targetingthefundamentals pages 2-4).

15. Model Organisms

Harmaline Model (Mouse/Rat)

The most widely used ET model involves systemic injection of harmaline (20–40 mg/kg) in C57BL/6J mice or Wistar rats, inducing 9–16 Hz action tremor through synchronized inferior olivary neuron firing that entrains Purkinje cell complex spike activity (pan2026circuitrydynamicsof pages 16-19, kuo2023gabaareceptorsubtype pages 1-2, kosmowska2023gabaaalpha23 pages 2-3, woodward2022cerebellothalamocorticalnetworkdynamics pages 1-2). This model demonstrates excellent predictive validity, as ethanol, benzodiazepines, primidone, and GABA-A receptor potentiators that reduce human tremor also suppress harmaline tremor (kosmowska2023gabaaalpha23 pages 2-3).

Grid2dupE3 Mouse Model

This genetic model features GluRδ2 loss and climbing fiber overgrowth, producing ET-like tremor with distinct neurodynamics — global Purkinje cell hypersynchrony and resistance to propranolol and inferior olive-targeted therapies (pan2026circuitrydynamicsof pages 16-19, pan2025targetingthefundamentals pages 2-4). This model represents a cerebellar pathology-driven ET subtype, contrasting with the harmaline model.

GABA-A Receptor Knockout Models

• α1 GABAA receptor knockout mice develop genetic essential tremor phenotype (kosmowska2023gabaaalpha23 pages 16-17, pan2026circuitrydynamicsof pages 32-34)
• Cerebellar Purkinje cell-specific α1 loss is sufficient to induce tremor, confirming the cerebellar origin (kosmowska2023gabaaalpha23 pages 16-17, pan2026circuitrydynamicsof pages 32-34)
• α6, δ, and β3 subunit knockouts do not produce tremor spontaneously but abolish alcohol-mediated tremor suppression, clarifying receptor mechanisms (handforth2023searchfornovel pages 1-2, kuo2023gabaareceptorsubtype pages 1-2)

Gut Microbiome Models

Fecal microbiota transplantation from ET patients into germ-free mice extended tremor duration and impaired mobility, establishing causal links between gut dysbiosis and ET phenotype (zhong2023supplementationwithhighgabaproducing pages 5-7, zhong2023supplementationwithhighgabaproducing pages 2-4).

Model Limitations

Both harmaline and genetic models capture only subsets of ET pathophysiology. The harmaline model is acute and involves a specific pharmacological mechanism, while the Grid2dupE3 model captures climbing fiber overgrowth but not the full etiological heterogeneity of human ET (pan2026circuitrydynamicsof pages 16-19, kosmowska2023gabaaalpha23 pages 2-3).

Summary

Essential tremor is a prevalent, genetically complex neurological disorder with a rapidly expanding understanding of its molecular and cellular underpinnings. Recent GWAS meta-analyses have identified up to 50 risk loci explaining ~24% SNP heritability, implicating genes involved in calcium signaling (CACNA1A, CALN1), neurotransmitter release (CPLX1), carbonic anhydrase biology (CA3), oligodendrocyte biology (BACE2), and axon guidance (TENM4) (skuladottir2024gwasmetaanalysisreveals pages 1-2, ogonowski2025genomewidemetaanalysisidentifies pages 3-5, castonguay2024asinglecelleqtl pages 1-5). The pathophysiology centers on cerebello-thalamo-cortical circuit dysfunction driven by Purkinje cell pathology, GABAergic dysregulation, and newly recognized oligodendrocyte vulnerability (ortegarobles2025tremorclinicalframeworks pages 13-15, camargo2025thecerebellarinvolvement pages 2-4, castonguay2024asinglecelleqtl pages 1-5). While propranolol and primidone remain first-line treatments with ~50–70% tremor reduction, they are limited by side effects and waning efficacy, creating significant unmet need for novel therapeutics targeting α6-GABAA receptors, dopamine D3 pathways, and neuroactive steroids (ortegarobles2025tremorclinicalframeworks pages 16-18, handforth2023searchfornovel pages 1-2, NCT07074002 chunk 1). Surgical options including DBS and focused ultrasound thalamotomy offer effective intervention for refractory cases (camargo2025thecerebellarinvolvement pages 7-8). The emerging role of the gut microbiome in ET pathogenesis through GABA-producing bacteria represents a potentially transformative therapeutic avenue (zhong2023supplementationwithhighgabaproducing pages 7-14, zhong2023supplementationwithhighgabaproducing pages 1-2).

References

1. (ortegarobles2025tremorclinicalframeworks pages 13-15): Emmanuel Ortega-Robles and Oscar Arias-Carrión. Tremor: clinical frameworks, network dysfunction and therapeutics. Brain Sciences, 15:799, Jul 2025. URL: https://doi.org/10.3390/brainsci15080799, doi:10.3390/brainsci15080799. This article has 9 citations.

2. (ortegarobles2025tremorclinicalframeworks pages 2-4): Emmanuel Ortega-Robles and Oscar Arias-Carrión. Tremor: clinical frameworks, network dysfunction and therapeutics. Brain Sciences, 15:799, Jul 2025. URL: https://doi.org/10.3390/brainsci15080799, doi:10.3390/brainsci15080799. This article has 9 citations.

3. (buyukserbetci2025clinicalandgenetic pages 1-2): Gulseren Buyukserbetci, Hilmi Bolat, Ummu Serpil Sari, Gizem Turan, Ayla Solmaz Avcikurt, and Figen Esmeli. Clinical and genetic characteristics of patients with essential tremor who develop parkinson’s disease. Medicina, 61:1184, Jun 2025. URL: https://doi.org/10.3390/medicina61071184, doi:10.3390/medicina61071184. This article has 0 citations.

4. (OpenTargets Search: Essential Tremor): Open Targets Query (Essential Tremor, 14 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

5. (kuhlenbaumer2014geneticsofessential pages 1-3): Gregor Kuhlenbäumer, Franziska Hopfner, and Günther Deuschl. Genetics of essential tremor. Neurology, 82(11):1000-1007, Mar 2022. URL: https://doi.org/10.1212/wnl.0000000000000211, doi:10.1212/wnl.0000000000000211. This article has 65 citations and is from a highest quality peer-reviewed journal.

6. (skuladottir2024gwasmetaanalysisreveals pages 1-2): Astros Th. Skuladottir, Lilja Stefansdottir, Gisli H. Halldorsson, Olafur A. Stefansson, Anna Bjornsdottir, Palmi Jonsson, Vala Palmadottir, Thorgeir E. Thorgeirsson, G. Bragi Walters, Rosa S. Gisladottir, Gyda Bjornsdottir, Gudrun A. Jonsdottir, Patrick Sulem, Daniel F. Gudbjartsson, Kirk U. Knowlton, David A. Jones, Aigar Ottas, Tõnu Esko, Reedik Mägi, Mari Nelis, Georgi Hudjashov, Ole B. Pedersen, Maria Didriksen, Søren Brunak, Karina Banasik, Thomas Folkmann Hansen, Christian Erikstrup, Jakob Bay, Jens Kjærgaard Boldsen, Thorsten Brodersen, Kristoffer Burgdorf, Mona Ameri Chalmer, Khoa Manh Dinh, Joseph Dowsett, Bjarke Feenstra, Frank Geller, Daniel Gudbjartsson, Lotte Hindhede, Henrik Hjalgrim, Rikke Louise Jacobsen, Gregor Jemec, Bitten Aagaard Jensen, Katrine Kaspersen, Bertram Dalskov Kjerulff, Lisette Kogelman, Margit Anita Hørup Larsen, Ioannis Louloudis, Agnete Lundgaard, Susan Mikkelsen, Christina Mikkelsen, Ioanna Nissen, Mette Nyegaard, Ole Birger Pedersen, Alexander Pil Henriksen, Palle Duun Rohde, Klaus Rostgaard, Michael Schwinn, Hreinn Stefánsson, Erik Sørensen, Unnur Þorsteinsdóttir, Lise Wegner Thørner, Mie Topholm Bruun, Henrik Ullum, Thomas Werge, David Westergaard, Jan Haavik, Ole A. Andreassen, David Rye, Jannicke Igland, Sisse Rye Ostrowski, Lili A. Milani, Lincoln D. Nadauld, Hreinn Stefansson, and Kari Stefansson. Gwas meta-analysis reveals key risk loci in essential tremor pathogenesis. Communications Biology, Apr 2024. URL: https://doi.org/10.1038/s42003-024-06207-4, doi:10.1038/s42003-024-06207-4. This article has 18 citations and is from a peer-reviewed journal.

7. (skuladottir2024gwasmetaanalysisreveals pages 2-4): Astros Th. Skuladottir, Lilja Stefansdottir, Gisli H. Halldorsson, Olafur A. Stefansson, Anna Bjornsdottir, Palmi Jonsson, Vala Palmadottir, Thorgeir E. Thorgeirsson, G. Bragi Walters, Rosa S. Gisladottir, Gyda Bjornsdottir, Gudrun A. Jonsdottir, Patrick Sulem, Daniel F. Gudbjartsson, Kirk U. Knowlton, David A. Jones, Aigar Ottas, Tõnu Esko, Reedik Mägi, Mari Nelis, Georgi Hudjashov, Ole B. Pedersen, Maria Didriksen, Søren Brunak, Karina Banasik, Thomas Folkmann Hansen, Christian Erikstrup, Jakob Bay, Jens Kjærgaard Boldsen, Thorsten Brodersen, Kristoffer Burgdorf, Mona Ameri Chalmer, Khoa Manh Dinh, Joseph Dowsett, Bjarke Feenstra, Frank Geller, Daniel Gudbjartsson, Lotte Hindhede, Henrik Hjalgrim, Rikke Louise Jacobsen, Gregor Jemec, Bitten Aagaard Jensen, Katrine Kaspersen, Bertram Dalskov Kjerulff, Lisette Kogelman, Margit Anita Hørup Larsen, Ioannis Louloudis, Agnete Lundgaard, Susan Mikkelsen, Christina Mikkelsen, Ioanna Nissen, Mette Nyegaard, Ole Birger Pedersen, Alexander Pil Henriksen, Palle Duun Rohde, Klaus Rostgaard, Michael Schwinn, Hreinn Stefánsson, Erik Sørensen, Unnur Þorsteinsdóttir, Lise Wegner Thørner, Mie Topholm Bruun, Henrik Ullum, Thomas Werge, David Westergaard, Jan Haavik, Ole A. Andreassen, David Rye, Jannicke Igland, Sisse Rye Ostrowski, Lili A. Milani, Lincoln D. Nadauld, Hreinn Stefansson, and Kari Stefansson. Gwas meta-analysis reveals key risk loci in essential tremor pathogenesis. Communications Biology, Apr 2024. URL: https://doi.org/10.1038/s42003-024-06207-4, doi:10.1038/s42003-024-06207-4. This article has 18 citations and is from a peer-reviewed journal.

8. (ogonowski2025genomewidemetaanalysisidentifies pages 3-5): Natalia S. Ogonowski, Fangyuan Cao, Victor Flores-Ocampo, Sofia Salazar-Magaña, Mathias Seviiri, Liyang Song, Sam Nayler, Jason Kugelman, Gabriel Cuellar-Partida, Stuart MacGregor, Hae Kyung Im, Ian H. Harding, Puya Gharahkhani, Nicholas G. Martin, Kishore R. Kumar, Jian Yang, Santiago Diaz-Torres, and Miguel E. Rentería. Genome-wide meta-analysis identifies 47 novel loci and links essential tremor to ventral diencephalon and cerebellum morphometry. MedRxiv, Nov 2025. URL: https://doi.org/10.1101/2025.11.10.25339873, doi:10.1101/2025.11.10.25339873. This article has 0 citations.

9. (ogonowski2025genomewidemetaanalysisidentifies pages 7-9): Natalia S. Ogonowski, Fangyuan Cao, Victor Flores-Ocampo, Sofia Salazar-Magaña, Mathias Seviiri, Liyang Song, Sam Nayler, Jason Kugelman, Gabriel Cuellar-Partida, Stuart MacGregor, Hae Kyung Im, Ian H. Harding, Puya Gharahkhani, Nicholas G. Martin, Kishore R. Kumar, Jian Yang, Santiago Diaz-Torres, and Miguel E. Rentería. Genome-wide meta-analysis identifies 47 novel loci and links essential tremor to ventral diencephalon and cerebellum morphometry. MedRxiv, Nov 2025. URL: https://doi.org/10.1101/2025.11.10.25339873, doi:10.1101/2025.11.10.25339873. This article has 0 citations.

10. (ogonowski2025genomewidemetaanalysisidentifies pages 1-3): Natalia S. Ogonowski, Fangyuan Cao, Victor Flores-Ocampo, Sofia Salazar-Magaña, Mathias Seviiri, Liyang Song, Sam Nayler, Jason Kugelman, Gabriel Cuellar-Partida, Stuart MacGregor, Hae Kyung Im, Ian H. Harding, Puya Gharahkhani, Nicholas G. Martin, Kishore R. Kumar, Jian Yang, Santiago Diaz-Torres, and Miguel E. Rentería. Genome-wide meta-analysis identifies 47 novel loci and links essential tremor to ventral diencephalon and cerebellum morphometry. MedRxiv, Nov 2025. URL: https://doi.org/10.1101/2025.11.10.25339873, doi:10.1101/2025.11.10.25339873. This article has 0 citations.

11. (kuhlenbaumer2014geneticsofessential pages 4-6): Gregor Kuhlenbäumer, Franziska Hopfner, and Günther Deuschl. Genetics of essential tremor. Neurology, 82(11):1000-1007, Mar 2022. URL: https://doi.org/10.1212/wnl.0000000000000211, doi:10.1212/wnl.0000000000000211. This article has 65 citations and is from a highest quality peer-reviewed journal.

12. (cao2023associationanalysisof pages 7-8): Lanxiao Cao, Luyan Gu, Jiali Pu, Dayao Lv, Jun Tian, Xinzhen Yin, Ting Gao, Zhe Song, Jinyu Lu, Gaohua Zhao, Baorong Zhang, Yaping Yan, and Guohua Zhao. Association analysis of 27 single nucleotide polymorphisms in a chinese population with essential tremor. Journal of Molecular Neuroscience, 73:205-213, Mar 2023. URL: https://doi.org/10.1007/s12031-023-02106-1, doi:10.1007/s12031-023-02106-1. This article has 2 citations and is from a peer-reviewed journal.

13. (kosmowska2023gabaaalpha23 pages 2-3): Barbara Kosmowska, Martyna Paleczna, Dominika Biała, Justyna Kadłuczka, Jadwiga Wardas, Jeffrey M. Witkin, James M. Cook, Dishary Sharmin, Monika Marcinkowska, and Katarzyna Z. Kuter. Gaba-a alpha 2/3 but not alpha 1 receptor subunit ligand inhibits harmaline and pimozide-induced tremor in rats. Biomolecules, 13:197, Jan 2023. URL: https://doi.org/10.3390/biom13020197, doi:10.3390/biom13020197. This article has 10 citations.

14. (handforth2023searchfornovel pages 1-2): Adrian Handforth, Ram P. Singh, Marco Treven, and Margot Ernst. Search for novel therapies for essential tremor based on positive modulation of α6-containing gabaa receptors. Tremor and Other Hyperkinetic Movements, Oct 2023. URL: https://doi.org/10.5334/tohm.796, doi:10.5334/tohm.796. This article has 10 citations and is from a peer-reviewed journal.

15. (kuo2023gabaareceptorsubtype pages 1-2): Sheng-Han Kuo. Gabaa receptor subtype specificity in essential tremor. Neurotherapeutics, 20:372-374, Mar 2023. URL: https://doi.org/10.1007/s13311-023-01341-z, doi:10.1007/s13311-023-01341-z. This article has 1 citations and is from a peer-reviewed journal.

16. (zhong2023supplementationwithhighgabaproducing pages 7-14): Hao-Jie Zhong, Si-Qi Wang, Ruo-Xin Zhang, Yu-Pei Zhuang, Longyan Li, Shuo-Zhao Yi, Ying Li, Lei Wu, Yu Ding, Jumei Zhang, Xinqiang Xie, Xing-Xiang He, and Qingping Wu. Supplementation with high-gaba-producing lactobacillus plantarum l5 ameliorates essential tremor triggered by decreased gut bacteria-derived gaba. Translational Neurodegeneration, Dec 2023. URL: https://doi.org/10.1186/s40035-023-00391-9, doi:10.1186/s40035-023-00391-9. This article has 52 citations and is from a domain leading peer-reviewed journal.

17. (zhong2023supplementationwithhighgabaproducing pages 1-2): Hao-Jie Zhong, Si-Qi Wang, Ruo-Xin Zhang, Yu-Pei Zhuang, Longyan Li, Shuo-Zhao Yi, Ying Li, Lei Wu, Yu Ding, Jumei Zhang, Xinqiang Xie, Xing-Xiang He, and Qingping Wu. Supplementation with high-gaba-producing lactobacillus plantarum l5 ameliorates essential tremor triggered by decreased gut bacteria-derived gaba. Translational Neurodegeneration, Dec 2023. URL: https://doi.org/10.1186/s40035-023-00391-9, doi:10.1186/s40035-023-00391-9. This article has 52 citations and is from a domain leading peer-reviewed journal.

18. (zhong2023supplementationwithhighgabaproducing pages 14-17): Hao-Jie Zhong, Si-Qi Wang, Ruo-Xin Zhang, Yu-Pei Zhuang, Longyan Li, Shuo-Zhao Yi, Ying Li, Lei Wu, Yu Ding, Jumei Zhang, Xinqiang Xie, Xing-Xiang He, and Qingping Wu. Supplementation with high-gaba-producing lactobacillus plantarum l5 ameliorates essential tremor triggered by decreased gut bacteria-derived gaba. Translational Neurodegeneration, Dec 2023. URL: https://doi.org/10.1186/s40035-023-00391-9, doi:10.1186/s40035-023-00391-9. This article has 52 citations and is from a domain leading peer-reviewed journal.

19. (ogonowski2025genomewidemetaanalysisidentifies pages 9-11): Natalia S. Ogonowski, Fangyuan Cao, Victor Flores-Ocampo, Sofia Salazar-Magaña, Mathias Seviiri, Liyang Song, Sam Nayler, Jason Kugelman, Gabriel Cuellar-Partida, Stuart MacGregor, Hae Kyung Im, Ian H. Harding, Puya Gharahkhani, Nicholas G. Martin, Kishore R. Kumar, Jian Yang, Santiago Diaz-Torres, and Miguel E. Rentería. Genome-wide meta-analysis identifies 47 novel loci and links essential tremor to ventral diencephalon and cerebellum morphometry. MedRxiv, Nov 2025. URL: https://doi.org/10.1101/2025.11.10.25339873, doi:10.1101/2025.11.10.25339873. This article has 0 citations.

20. (skuladottir2024gwasmetaanalysisreveals pages 4-4): Astros Th. Skuladottir, Lilja Stefansdottir, Gisli H. Halldorsson, Olafur A. Stefansson, Anna Bjornsdottir, Palmi Jonsson, Vala Palmadottir, Thorgeir E. Thorgeirsson, G. Bragi Walters, Rosa S. Gisladottir, Gyda Bjornsdottir, Gudrun A. Jonsdottir, Patrick Sulem, Daniel F. Gudbjartsson, Kirk U. Knowlton, David A. Jones, Aigar Ottas, Tõnu Esko, Reedik Mägi, Mari Nelis, Georgi Hudjashov, Ole B. Pedersen, Maria Didriksen, Søren Brunak, Karina Banasik, Thomas Folkmann Hansen, Christian Erikstrup, Jakob Bay, Jens Kjærgaard Boldsen, Thorsten Brodersen, Kristoffer Burgdorf, Mona Ameri Chalmer, Khoa Manh Dinh, Joseph Dowsett, Bjarke Feenstra, Frank Geller, Daniel Gudbjartsson, Lotte Hindhede, Henrik Hjalgrim, Rikke Louise Jacobsen, Gregor Jemec, Bitten Aagaard Jensen, Katrine Kaspersen, Bertram Dalskov Kjerulff, Lisette Kogelman, Margit Anita Hørup Larsen, Ioannis Louloudis, Agnete Lundgaard, Susan Mikkelsen, Christina Mikkelsen, Ioanna Nissen, Mette Nyegaard, Ole Birger Pedersen, Alexander Pil Henriksen, Palle Duun Rohde, Klaus Rostgaard, Michael Schwinn, Hreinn Stefánsson, Erik Sørensen, Unnur Þorsteinsdóttir, Lise Wegner Thørner, Mie Topholm Bruun, Henrik Ullum, Thomas Werge, David Westergaard, Jan Haavik, Ole A. Andreassen, David Rye, Jannicke Igland, Sisse Rye Ostrowski, Lili A. Milani, Lincoln D. Nadauld, Hreinn Stefansson, and Kari Stefansson. Gwas meta-analysis reveals key risk loci in essential tremor pathogenesis. Communications Biology, Apr 2024. URL: https://doi.org/10.1038/s42003-024-06207-4, doi:10.1038/s42003-024-06207-4. This article has 18 citations and is from a peer-reviewed journal.

21. (castonguay2024asinglecelleqtl pages 1-5): Charles-Etienne Castonguay, Farah Aboasali, Miranda Medeiros, Théodore Becret, Zoe Schmilovich, Anouar Khayachi, Alex Rajput, Patrick A. Dion, and Guy A Rouleau. A single-cell eqtl atlas of the human cerebellum reveals vulnerability of oligodendrocytes in essential tremor. bioRxiv, May 2024. URL: https://doi.org/10.1101/2024.05.22.595233, doi:10.1101/2024.05.22.595233. This article has 6 citations.

22. (zeng2024associationanalysisof pages 8-9): Sheng Zeng, Xun Zhou, Runcheng He, Yuwen Zhao, Zhenhua Liu, Qian Xu, Jifeng Guo, Xinxiang Yan, Jinchen Li, Beisha Tang, and Qiying Sun. Association analysis of essential tremor-associated genetic variants in sporadic late-onset parkinson’s disease. Tremor and Other Hyperkinetic Movements, May 2024. URL: https://doi.org/10.5334/tohm.885, doi:10.5334/tohm.885. This article has 2 citations and is from a peer-reviewed journal.

23. (ortegarobles2025tremorclinicalframeworks pages 15-16): Emmanuel Ortega-Robles and Oscar Arias-Carrión. Tremor: clinical frameworks, network dysfunction and therapeutics. Brain Sciences, 15:799, Jul 2025. URL: https://doi.org/10.3390/brainsci15080799, doi:10.3390/brainsci15080799. This article has 9 citations.

24. (erro2023diagnosisversusclassification pages 2-3): Roberto Erro, Marina Picillo, Maria Teresa Pellecchia, and Paolo Barone. Diagnosis versus classification of essential tremor: a research perspective. Journal of Movement Disorders, 16:152-157, May 2023. URL: https://doi.org/10.14802/jmd.23020, doi:10.14802/jmd.23020. This article has 7 citations and is from a peer-reviewed journal.

25. (ortegarobles2025tremorclinicalframeworks pages 10-12): Emmanuel Ortega-Robles and Oscar Arias-Carrión. Tremor: clinical frameworks, network dysfunction and therapeutics. Brain Sciences, 15:799, Jul 2025. URL: https://doi.org/10.3390/brainsci15080799, doi:10.3390/brainsci15080799. This article has 9 citations.

26. (ortegarobles2025tremorclinicalframeworks pages 12-13): Emmanuel Ortega-Robles and Oscar Arias-Carrión. Tremor: clinical frameworks, network dysfunction and therapeutics. Brain Sciences, 15:799, Jul 2025. URL: https://doi.org/10.3390/brainsci15080799, doi:10.3390/brainsci15080799. This article has 9 citations.

27. (martuscello2023geneexpressionanalysis pages 9-11): Regina T. Martuscello, Karthigayini Sivaprakasam, Whitney Hartstone, Sheng-Han Kuo, Genevieve Konopka, Elan D. Louis, and Phyllis L. Faust. Gene expression analysis of laser-captured purkinje cells in the essential tremor cerebellum. The Cerebellum, 22:1166-1181, Oct 2023. URL: https://doi.org/10.1007/s12311-022-01483-4, doi:10.1007/s12311-022-01483-4. This article has 13 citations.

28. (zhong2023supplementationwithhighgabaproducing pages 5-7): Hao-Jie Zhong, Si-Qi Wang, Ruo-Xin Zhang, Yu-Pei Zhuang, Longyan Li, Shuo-Zhao Yi, Ying Li, Lei Wu, Yu Ding, Jumei Zhang, Xinqiang Xie, Xing-Xiang He, and Qingping Wu. Supplementation with high-gaba-producing lactobacillus plantarum l5 ameliorates essential tremor triggered by decreased gut bacteria-derived gaba. Translational Neurodegeneration, Dec 2023. URL: https://doi.org/10.1186/s40035-023-00391-9, doi:10.1186/s40035-023-00391-9. This article has 52 citations and is from a domain leading peer-reviewed journal.

29. (ortegarobles2025tremorclinicalframeworks pages 6-8): Emmanuel Ortega-Robles and Oscar Arias-Carrión. Tremor: clinical frameworks, network dysfunction and therapeutics. Brain Sciences, 15:799, Jul 2025. URL: https://doi.org/10.3390/brainsci15080799, doi:10.3390/brainsci15080799. This article has 9 citations.

30. (camargo2025thecerebellarinvolvement pages 2-4): Carlos Henrique Ferreira Camargo, Léo Coutinho, Luis Eduardo Borges de Macedo Zubko, G. Franklin, and Hélio Afonso Ghizoni Teive. The cerebellar involvement in essential tremor: the connecting roads. Arquivos de Neuro-Psiquiatria, 83:001-012, Oct 2025. URL: https://doi.org/10.1055/s-0045-1812324, doi:10.1055/s-0045-1812324. This article has 0 citations and is from a peer-reviewed journal.

31. (camargo2025thecerebellarinvolvement pages 1-2): Carlos Henrique Ferreira Camargo, Léo Coutinho, Luis Eduardo Borges de Macedo Zubko, G. Franklin, and Hélio Afonso Ghizoni Teive. The cerebellar involvement in essential tremor: the connecting roads. Arquivos de Neuro-Psiquiatria, 83:001-012, Oct 2025. URL: https://doi.org/10.1055/s-0045-1812324, doi:10.1055/s-0045-1812324. This article has 0 citations and is from a peer-reviewed journal.

32. (martuscello2023geneexpressionanalysis pages 12-14): Regina T. Martuscello, Karthigayini Sivaprakasam, Whitney Hartstone, Sheng-Han Kuo, Genevieve Konopka, Elan D. Louis, and Phyllis L. Faust. Gene expression analysis of laser-captured purkinje cells in the essential tremor cerebellum. The Cerebellum, 22:1166-1181, Oct 2023. URL: https://doi.org/10.1007/s12311-022-01483-4, doi:10.1007/s12311-022-01483-4. This article has 13 citations.

33. (martuscello2023geneexpressionanalysis pages 6-7): Regina T. Martuscello, Karthigayini Sivaprakasam, Whitney Hartstone, Sheng-Han Kuo, Genevieve Konopka, Elan D. Louis, and Phyllis L. Faust. Gene expression analysis of laser-captured purkinje cells in the essential tremor cerebellum. The Cerebellum, 22:1166-1181, Oct 2023. URL: https://doi.org/10.1007/s12311-022-01483-4, doi:10.1007/s12311-022-01483-4. This article has 13 citations.

34. (kosmowska2023gabaaalpha23 pages 16-17): Barbara Kosmowska, Martyna Paleczna, Dominika Biała, Justyna Kadłuczka, Jadwiga Wardas, Jeffrey M. Witkin, James M. Cook, Dishary Sharmin, Monika Marcinkowska, and Katarzyna Z. Kuter. Gaba-a alpha 2/3 but not alpha 1 receptor subunit ligand inhibits harmaline and pimozide-induced tremor in rats. Biomolecules, 13:197, Jan 2023. URL: https://doi.org/10.3390/biom13020197, doi:10.3390/biom13020197. This article has 10 citations.

35. (pan2026circuitrydynamicsof pages 32-34): Ming-Kai Pan, Liang-Ying Chen, Yi-Mei Wang, Alexander White, Jou-Yu Ho, Shun-Ying Chen, Yi-Fan Chen, Ting-Yu Liang, Liang-Yin Lu, Ting-Yi Kuo, Wen-Chuan Liu, Jye-Chang Lee, David Friel, Peter Thomas, Shusen Pu, Sheng-Han Kuo, Shi-Wei Chu, Shun-Chi Wu, Chung-Chuan Lo, and George Ermentrout. Circuitry dynamics of the cerebellum inform differential therapeutic responses and patient stratification in essential tremor. Unknown journal, Feb 2026. URL: https://doi.org/10.21203/rs.3.rs-8705665/v1, doi:10.21203/rs.3.rs-8705665/v1.

36. (gironell2022isessentialtremor pages 1-2): Alexandre Gironell. Is essential tremor a disorder of primary gaba dysfunction? yes. International review of neurobiology, 163:259-284, Jan 2022. URL: https://doi.org/10.1016/bs.irn.2022.02.005, doi:10.1016/bs.irn.2022.02.005. This article has 13 citations and is from a peer-reviewed journal.

37. (woodward2022cerebellothalamocorticalnetworkdynamics pages 1-2): Kathryn Woodward, Richard Apps, Marc Goodfellow, and Nadia L. Cerminara. Cerebello-thalamo-cortical network dynamics in the harmaline rodent model of essential tremor. Frontiers in Systems Neuroscience, Jul 2022. URL: https://doi.org/10.3389/fnsys.2022.899446, doi:10.3389/fnsys.2022.899446. This article has 8 citations and is from a peer-reviewed journal.

38. (castonguay2024asinglecelleqtl pages 45-47): Charles-Etienne Castonguay, Farah Aboasali, Miranda Medeiros, Théodore Becret, Zoe Schmilovich, Anouar Khayachi, Alex Rajput, Patrick A. Dion, and Guy A Rouleau. A single-cell eqtl atlas of the human cerebellum reveals vulnerability of oligodendrocytes in essential tremor. bioRxiv, May 2024. URL: https://doi.org/10.1101/2024.05.22.595233, doi:10.1101/2024.05.22.595233. This article has 6 citations.

39. (castonguay2022transcriptomiceffectsof pages 3-4): Charles-Etienne Castonguay, Calwing Liao, Anouar Khayachi, Yumin Liu, Miranda Medeiros, Gabrielle Houle, Jay P. Ross, Patrick A. Dion, and Guy A. Rouleau. Transcriptomic effects of propranolol and primidone converge on molecular pathways relevant to essential tremor. npj Genomic Medicine, Aug 2022. URL: https://doi.org/10.1038/s41525-022-00318-9, doi:10.1038/s41525-022-00318-9. This article has 13 citations and is from a peer-reviewed journal.

40. (castonguay2022transcriptomiceffectsof pages 1-2): Charles-Etienne Castonguay, Calwing Liao, Anouar Khayachi, Yumin Liu, Miranda Medeiros, Gabrielle Houle, Jay P. Ross, Patrick A. Dion, and Guy A. Rouleau. Transcriptomic effects of propranolol and primidone converge on molecular pathways relevant to essential tremor. npj Genomic Medicine, Aug 2022. URL: https://doi.org/10.1038/s41525-022-00318-9, doi:10.1038/s41525-022-00318-9. This article has 13 citations and is from a peer-reviewed journal.

41. (camargo2025thecerebellarinvolvement pages 7-8): Carlos Henrique Ferreira Camargo, Léo Coutinho, Luis Eduardo Borges de Macedo Zubko, G. Franklin, and Hélio Afonso Ghizoni Teive. The cerebellar involvement in essential tremor: the connecting roads. Arquivos de Neuro-Psiquiatria, 83:001-012, Oct 2025. URL: https://doi.org/10.1055/s-0045-1812324, doi:10.1055/s-0045-1812324. This article has 0 citations and is from a peer-reviewed journal.

42. (castonguay2024asinglecelleqtl pages 31-33): Charles-Etienne Castonguay, Farah Aboasali, Miranda Medeiros, Théodore Becret, Zoe Schmilovich, Anouar Khayachi, Alex Rajput, Patrick A. Dion, and Guy A Rouleau. A single-cell eqtl atlas of the human cerebellum reveals vulnerability of oligodendrocytes in essential tremor. bioRxiv, May 2024. URL: https://doi.org/10.1101/2024.05.22.595233, doi:10.1101/2024.05.22.595233. This article has 6 citations.

43. (louis2023conversionrateof pages 4-5): Elan D. Louis, Diane Berry, Ali Ghanem, and Stephanie A. Cosentino. Conversion rate of essential tremor to essential tremor parkinson disease. Neurology Clinical Practice, Jun 2023. URL: https://doi.org/10.1212/cpj.0000000000200162, doi:10.1212/cpj.0000000000200162. This article has 33 citations.

44. (louis2023conversionrateof pages 1-2): Elan D. Louis, Diane Berry, Ali Ghanem, and Stephanie A. Cosentino. Conversion rate of essential tremor to essential tremor parkinson disease. Neurology Clinical Practice, Jun 2023. URL: https://doi.org/10.1212/cpj.0000000000200162, doi:10.1212/cpj.0000000000200162. This article has 33 citations.

45. (louis2025theassociationbetween pages 4-5): Elan D. Louis. The association between essential tremor and parkinson’s disease: a systematic review of clinical and epidemiological studies. Journal of Clinical Medicine, 14:2637, Apr 2025. URL: https://doi.org/10.3390/jcm14082637, doi:10.3390/jcm14082637. This article has 15 citations.

46. (lin2025prevalenceofdiagnosed pages 1-2): Junji Lin, Rajesh Pahwa, Elan D. Louis, Ragy Saad, Kelly E. Lyons, Michael Markowitz, Liza R. Gibbs, Aisara Chansakul, John Kroner, Douglas S. Fuller, Weiyi Ni, Arthur Sillah, Michelle Baladi, Luigi M. Barbato, and Sanket Shah. Prevalence of diagnosed essential tremor in the united states: an administrative claims-based study. Tremor and Other Hyperkinetic Movements, 15:51, Oct 2025. URL: https://doi.org/10.5334/tohm.1060, doi:10.5334/tohm.1060. This article has 1 citations and is from a peer-reviewed journal.

47. (lin2025prevalenceofdiagnosed pages 8-10): Junji Lin, Rajesh Pahwa, Elan D. Louis, Ragy Saad, Kelly E. Lyons, Michael Markowitz, Liza R. Gibbs, Aisara Chansakul, John Kroner, Douglas S. Fuller, Weiyi Ni, Arthur Sillah, Michelle Baladi, Luigi M. Barbato, and Sanket Shah. Prevalence of diagnosed essential tremor in the united states: an administrative claims-based study. Tremor and Other Hyperkinetic Movements, 15:51, Oct 2025. URL: https://doi.org/10.5334/tohm.1060, doi:10.5334/tohm.1060. This article has 1 citations and is from a peer-reviewed journal.

48. (becktepe2025epidemiologyandtreatment pages 1-2): Jos S. Becktepe, Keltie McDonald, Sabrina Müller, Thomas Wilke, Evi Zhuleku, Karen Appiah, Natasha Dzimitrowicz, Jade Marshall, Javier Sabater, Luigi M. Barbato, and Tabish A. Saifee. Epidemiology and treatment patterns of essential tremor: a retrospective cohort analysis in germany. Frontiers in Neurology, Jul 2025. URL: https://doi.org/10.3389/fneur.2025.1580919, doi:10.3389/fneur.2025.1580919. This article has 4 citations and is from a peer-reviewed journal.

49. (NCT04748640 chunk 1): Christian Iorio-Morin. Bilateral Essential Tremor Treatment With Gamma Knife. Université de Sherbrooke. 2021. ClinicalTrials.gov Identifier: NCT04748640

50. (ortegarobles2025tremorclinicalframeworks pages 16-18): Emmanuel Ortega-Robles and Oscar Arias-Carrión. Tremor: clinical frameworks, network dysfunction and therapeutics. Brain Sciences, 15:799, Jul 2025. URL: https://doi.org/10.3390/brainsci15080799, doi:10.3390/brainsci15080799. This article has 9 citations.

51. (zhang2024treatmentforessential pages 13-13): Junjiao Zhang, Rui Yan, Yu-Ling Cui, Dongning Su, and Tao Feng. Treatment for essential tremor: a systematic review and bayesian model-based network meta-analysis of rcts. eClinicalMedicine, Oct 2024. URL: https://doi.org/10.1016/j.eclinm.2024.102889, doi:10.1016/j.eclinm.2024.102889. This article has 14 citations and is from a peer-reviewed journal.

52. (alharbi2024thepharmacologicalmanagement pages 9-9): Oqab Alharbi, Sofian A Albaibi, Abdullah A Almutairi, Emad Alsaqabi, Meshal Alharbi, Bader S Alharbi, Mohammad F Almansour, and Zainah A Al-Qahtani. The pharmacological management of essential tremor and its long-term effects on patient quality of life: a systematic review. Cureus, Dec 2024. URL: https://doi.org/10.7759/cureus.76016, doi:10.7759/cureus.76016. This article has 7 citations.

53. (NCT07074002 chunk 1): Proof of Concept Study on BP1.4979 Effect on Essential Tremor. Bioprojet. 2025. ClinicalTrials.gov Identifier: NCT07074002

54. (NCT07673107 chunk 1): Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential Tremor. AbbVie. 2026. ClinicalTrials.gov Identifier: NCT07673107

55. (pan2025targetingthefundamentals pages 2-4): Ming-Kai Pan. Targeting the fundamentals for tremors: the frequency and amplitude coding in essential tremor. Journal of Biomedical Science, Feb 2025. URL: https://doi.org/10.1186/s12929-024-01112-8, doi:10.1186/s12929-024-01112-8. This article has 10 citations and is from a domain leading peer-reviewed journal.

56. (pan2026circuitrydynamicsof pages 16-19): Ming-Kai Pan, Liang-Ying Chen, Yi-Mei Wang, Alexander White, Jou-Yu Ho, Shun-Ying Chen, Yi-Fan Chen, Ting-Yu Liang, Liang-Yin Lu, Ting-Yi Kuo, Wen-Chuan Liu, Jye-Chang Lee, David Friel, Peter Thomas, Shusen Pu, Sheng-Han Kuo, Shi-Wei Chu, Shun-Chi Wu, Chung-Chuan Lo, and George Ermentrout. Circuitry dynamics of the cerebellum inform differential therapeutic responses and patient stratification in essential tremor. Unknown journal, Feb 2026. URL: https://doi.org/10.21203/rs.3.rs-8705665/v1, doi:10.21203/rs.3.rs-8705665/v1.

57. (zhong2023supplementationwithhighgabaproducing pages 2-4): Hao-Jie Zhong, Si-Qi Wang, Ruo-Xin Zhang, Yu-Pei Zhuang, Longyan Li, Shuo-Zhao Yi, Ying Li, Lei Wu, Yu Ding, Jumei Zhang, Xinqiang Xie, Xing-Xiang He, and Qingping Wu. Supplementation with high-gaba-producing lactobacillus plantarum l5 ameliorates essential tremor triggered by decreased gut bacteria-derived gaba. Translational Neurodegeneration, Dec 2023. URL: https://doi.org/10.1186/s40035-023-00391-9, doi:10.1186/s40035-023-00391-9. This article has 52 citations and is from a domain leading peer-reviewed journal.

Artifacts

• Edison artifact artifact-00
• Edison artifact artifact-01